Loading…
Rodo Medical and Straumann Group announced that Straumann increased its stake in Rodo Medical from 12% to 30% and obtained exclusive distribution rights for Rodo's Smileloc dental implant retention devices outside North America and South Korea, with an option to increase to 51% in 2021.